+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Gene Therapy Market 2024-2028 - Product Thumbnail Image

Gene Therapy Market 2024-2028

  • Report
  • June 2024
  • 177 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • United States
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • May 2019
  • 480 Pages
  • Global
From
Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Cancer Immunotherapy Market Report, Forecast by Products, Application, End Users, Countries and Company Analysis, 2024-2032 - Product Thumbnail Image

Cancer Immunotherapy Market Report, Forecast by Products, Application, End Users, Countries and Company Analysis, 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

  • Report
  • April 2024
  • 138 Pages
  • Global
Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution? - Product Thumbnail Image

Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution?

  • Report
  • October 2021
  • 72 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

  • Report
  • June 2024
  • 64 Pages
  • Global
Cardiovascular Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Cardiovascular Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

  • Report
  • October 2021
  • 210 Pages
  • Global
From
Antihyperlipidemic Drugs Market Report by Drug Class, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Antihyperlipidemic Drugs Market Report by Drug Class, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • July 2024
  • 136 Pages
  • Global
From
Congestive Heart Failure Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Congestive Heart Failure Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Hyperlipidemia Drugs Market Report by Drug Type, End User, and Region 2024-2032 - Product Thumbnail Image

Hyperlipidemia Drugs Market Report by Drug Type, End User, and Region 2024-2032

  • Report
  • August 2024
  • 146 Pages
  • Global
From
Type 4 cyclic nucleotide phosphodiesterase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Type 4 cyclic nucleotide phosphodiesterase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 70 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups

  • Report
  • May 2024
  • 59 Pages
  • United Kingdom
Human Recombinant DNA: Global Markets - Product Thumbnail Image

Human Recombinant DNA: Global Markets

  • Report
  • July 2022
  • 84 Pages
  • Global
From
Loading Indicator